National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.13 per share, beating the Zacks Consensus Estimate of $1.10 per share. This compares to FFO of $1.09 per share a year ago.
MURFREESBORO, TN / ACCESSWIRE / January 14, 2025 / It is with great sorrow that National Health Investors, Inc. (NYSE:NHI) acknowledges the loss of our long-time colleague and great friend, Joe Wakham. Joe was with NHI for 16 years and his personality and influence is woven into the cultural fabric of our Company.
MURFREESBORO, TN / ACCESSWIRE / January 8, 2025 / National Health Investors, Inc. (NYSE:NHI) announced a series of changes to the Board of Directors which enhances the Board's ability to provide strategic and independent guidance. The changes include the following: Robert A.
National Health Investors has seen a pullback in price, resulting in a more attractive valuation with a 5% yield. NHI is seeing occupancy and tenant rent coverage improvements. Further growth in occupancy to 90% could result in margin expansion. With a strong balance sheet, solid dividend yield, and growth potential, NHI stock offers an attractive risk-reward opportunity at the current price.
National Health Investors, Inc. (NYSE:NHI ) Q3 2024 Earnings Conference Call November 6, 2024 11:00 AM ET Company Participants Dana Hambly – Vice President of Finance and Investor Relations Eric Mendelsohn – President and Chief Executive Officer Kevin Pascoe – Chief Investment Officer John Spaid – Chief Financial Officer Conference Call Participants Robin Haneland – BMO Rich Anderson – Wedbush Farrell Granath – Bank of America Omotayo Okusanya – Deutsche Bank Austin Wurschmidt – KeyBanc Capital Markets John Kilichowski – Wells Fargo Operator Greetings and welcome to the National Health Investors Third Quarter 2024 Earnings Webcast and Conference Call. At this time all participants are on a listen-only mode.
While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.03 per share, missing the Zacks Consensus Estimate of $1.07 per share. This compares to FFO of $1.08 per share a year ago.
MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that after more than 30 years of leadership, W. Andrew "Andy" Adams has notified the Board of Directors of National Health Investors, Inc. that he plans to retire as Chairman of the Board effective December 31, 2024.
MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com). Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.
MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its fourth quarter dividend of $0.90 per common share on January 29, 2025 to stockholders of record as of December 31, 2024. About NHI Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.
MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2024. Financial Results and Recent Events Net income attributable to common stockholders per diluted common share for the three months ended September 30, 2024 was $0.65 compared to $0.68 during the same period in the prior year.
The heavy selling pressure might have exhausted for National Health Investors (NHI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.